Apollo Hospital’s revenue in Q4FY18 grew by 14.7% yoy to Rs1,862.9cr. EBITDA increased by 25.6% yoy to Rs213.6cr from Rs170.1cr in Q4FY17. EBITDA margins in Q4FY18 were at 11.5% vs. 10.5% in Q4FY17 and 11.9% in Q3FY18. PAT grew by 23.8% yoy to Rs59.6cr in Q4FY18 vs. Rs48.2cr in Q4FY17.
Results are slightly below the consensus street estimates.
Healthcare segment revenue grew by 10.5% yoy to Rs 1,000cr in Q4FY18.
Healthcare segment EBIT margins at 10.9% in Q4FY18 vs. 9.2% in Q4FY17 and 12.1% in Q3FY18.
Pharmacy segment revenue grew by 20% yoy to Rs863.1cr in Q4FY18.
Pharmacy segment EBIT margins at 3.7% in Q4FY18 vs. 3.4% in Q4FY17 and 3.8% in Q3FY18.
Apollo Hospitals Enterprise Ltd is currently trading at Rs. 984, down by 20.8 points or 2.07% from its previous closing of Rs. 1,004.80 on the BSE.
The scrip opened at Rs. 993.25 and has touched a high and low of Rs. 999 and Rs. 976.35 respectively. So far 2,33,937 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 200 DMA.
Please use the temporary password sent on your email id or mobile no.
Update Mobile no.
Why you need to update your Mobile number ?
By providing verified mobile number we provide more exclusive information in the website.
Update Mobile no.
Terms & Conditions
By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in National Do Not Call Registry as laid down by Telecom Regulatory Authority of India will not be applicable for such information/ communication.